Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccinations in immunosuppressed patients]

O Bouchaud1

  • 1Service des Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude Bernard, Paris.

Annales De Medecine Interne
|January 1, 1997
PubMed
Summary

Vaccination in immunocompromised individuals presents risks and reduced efficacy. Live vaccines pose complications, while inactivated vaccines yield weaker responses, necessitating further research for optimal schedules.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intra-abdominal abscesses: Microbiological epidemiology and empirical antibiotherapy.

Infectious diseases now·2022
Same author

Tuberculosis treatment outcomes among precarious patients in France.

Infectious diseases now·2022
Same author

A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.

Journal of virology·2021
Same author

Pulmonary tuberculosis: Evaluation of current diagnostic strategy.

Infectious diseases now·2020
Same author

Management and prevention of imported malaria. 2018 update of the 2007 French clinical guidelines.

Medecine et maladies infectieuses·2020
Same author

New guidelines for the prevention of imported malaria in France.

Medecine et maladies infectieuses·2019

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Immunization is crucial for preventing infectious diseases in immunocompromised individuals.
  • Live attenuated vaccines carry risks of complications, particularly in severely immunocompromised patients.
  • Killed or inactivated vaccines are safe but elicit reduced immune responses.

Purpose of the Study:

  • To review the considerations and challenges of vaccination in immunocompromised populations.
  • To discuss the risks and benefits of live and inactivated vaccines in immune deficiency.
  • To highlight the need for further evaluation of modified vaccine schedules and their impact on viral replication in HIV-infected individuals.

Main Methods:

  • Literature review of vaccination strategies in immunocompromised states.
  • Analysis of risks associated with live attenuated and inactivated vaccines.
  • Discussion of vaccine efficacy and safety in specific conditions like HIV infection.

Main Results:

  • Live vaccines can cause post-immunization complications in severely immunocompromised individuals.
  • Inactivated vaccines show no contraindications but result in diminished immune responses.
  • Modified vaccine schedules (e.g., higher doses, boosters) require systematic evaluation.
  • The impact of vaccination on viral replication in HIV-infected individuals needs assessment.

Conclusions:

  • Vaccination in immunocompromised individuals requires careful risk-benefit assessment.
  • Current evidence is insufficient to establish definitive recommendations for modified vaccine schedules.
  • In developing countries, live vaccines may still be recommended for HIV+ children due to high disease prevalence.

Related Experiment Videos